Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of Onward Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Onward Therapeutics
Switzerland Flag
Country
Country
Switzerland
Address
Address
Route de la Corniche 8 1066 Epalinges
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

OT-A201 is a first-in-class bispecific antibody, which is currently being evalauted in phase 1 clinical trials for the treatment of hematological malignancy & solid tumor.


Lead Product(s): OT-A201

Therapeutic Area: Oncology Product Name: OT-A201

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Biomunex Pharmaceutical

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 24, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY